Summary
The effects of a twice daily dosage of a combination of 410 mg sulphadiazine + 90 mg trimethoprim (SD + TMP) and 800 mg sulphamethoxazole + 160 mg trimethoprim (SMZ + TMP) were compared in uncomplicated urinary tract infections. All but one patient in each treatment group, i.e. 36 SD + TMP treated and 42 SMZ + TMP treated patients respectively, were cured. The percentage of side-effects related to therapy in the patients receiving the combination with sulphadiazine was 15.1% and in those with sulphamethoxazole 23.7%. Due to the small number tested, however, differences were not statistically different. It is noteworthy that only one of the SD + TMP patients had to stop therapy because of a rash, whereas therapy was stopped for this reason in three of the SMZ + TMP patients. SD + TMP represents a good alternative to SMZ + TMP in the treatment of urinary tract infections.
Zusammenfassung
Die Wirksamkeit einer Kombination von 410 mg Sulphadiazin + 90 mg Trimethoprim (SD + TMP) und 800 mg Sulphamethoxazol + 160 mg Trimethoprim (SMZ + TMP) bei zweimaliger Verabreichung/die wurde bei unkomplizierten Harnwegsinfektionen verglichen. In jeder Behandlungsgruppe wurden alle bis auf einen Patienten geheilt, d. h. 36 SD- + TMP-Behandelte und 42 SMZ- + TMP-Behandelte. Der Prozentsatz an mit der Therapie verbundenen Nebenwirkungen war bei den Patienten, die die Kombination mit Sulfadiazin erhielten 15,1% und bei denen, die Sulfamethoxazol erhielten 23,7%. Wegen der kleinen Fallzahl waren jedoch diese Unterschiede statistisch nicht belegbar. Es ist bemerkenswert, daß nur einer der SD- + TMP-Patienten die Therapie wegen eines Exanthems unterbrechen mußte, während dies bei drei der SMZ- + TMP-Patienten geschah. SD + TMP stellt eine gute Alternative für SMZ + TMP bei Harnwegsinfektionen dar.
Similar content being viewed by others
Literature
Acar, J., Ekström, B., Fellner, H., Forsgren, U., Guibert, J., Huitfeldt, B., Kitzis, M. D., Magni, L., Örtengren, B. Synergistic activity of co-trimazine and co-trimoxazole in the urine. Infection 7, Suppl. 4 (1979) 324–328.
Böhni, E. Bacteriostatic and bactericidal activity of two trimethoprim-sulphonamide combinations. Chemotherapy 22 (1976) 262–273.
Bergan, T., Brodwall, E. K. Human pharmacokinetics of a sulphamethoxazole-trimethoprim combination. Acta Med. Scand. 1972 (1972) 483–492.
Harding, G. K. M., Ronald, A. R. Efficacy of trimethoprim-sulphamethoxazole in bacteriuria. In:Finland, M., Kass, E. H. (ed.): Trimethoprim-sulphamethoxazole. Microbiological, pharmacological, and clinical considerations. University of Chicago Press, Chicago, 1974, p. 209–214.
Männistö, P., Tuomisto, J., Saris, N.-E., Lehtinen, T. Pharmacokinetic studies with trimethoprim and different doses of sulphadiazine in healthy human subjects. Chemotherapy 19 (1973) 289–298.
Bergan, T., Vik-Mo, H., Ånstad, U. Kinetics of a sulphadiazine-trimethoprim combination. Clin. Pharmacol. Ther. 22 (1977) 211–224.
Ericsson, H. Rational use of antibiotics in hospitals. Scand. J. Clin. Lab. Invest. 12 Suppl. 50 (1960) 11–22.
Ekström, B., Fellner, H., Forsgren, U., Magni, L., Örtengren, B.: Antibacterial activity of co-trimazine in vitro and in vivo. Infection (1979) in press.
Tuomisto, J., Saris, N.-E. Effective plasma and urine concentratins of some sulphonamides and sulphonamide combinations. Ann. Med. Exp. Fenn 48 (1970) 38–48.
Brumfitt, W., Pursell, R. Trimethoprim-sulphamethoxazole in the treatment of bacteriuria in women. In:Finland, M., Kass, E. H. (ed.): Trimethoprim-sulphamethoxazole. Microbiological, pharmacological, and clinical considerations. University of Chicago Press, Chicago, 1974, p. 225–231.
Elsborg, L., Andreasen, F., Scherwin, J., Bülow, P. Et nyt lavt doserbart trimetoprim-sulfonamid til langtidsbehandling af kronisk urinvejsinfektion. Ugeskr. Laeg. 138 (1976) 735–737.
Tuomisto, J., Kasanen, A., Renkonen, O.-V. Sulphadiazine-trimethoprim combination in the treatment of urinary tract infections. Chemotherapy 23 (1977) 337–344.
Clark, C. J., Downie, C. C. A method for the rapid determination of a number of patients to include in a controlled clinical trial. Lancet II (1966) 1357–1358.
Krüger-Thiemer, E., Bünger, P. Evaluation of the risk of crystalluria with sulpha drugs. Proc. Eur. Soc. Drug. Tox. 6 (1965) 185–207.
Lehr, D. Clinical toxicity of sulphonamides. Ann. N. Y. Acad. Sci. 69 (1957) 417–447.
Plummer, M. N., Wheeler, C. The toxicity of sulphadiazine. Observations on 1357 cases. Am. J. Med. Sci. 207 (1944) 175–184.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Skjerven, O., Bergan, T. Double-blind comparison of sulphonamide-trimethoprim combinations in acute uncomplicated urinary tract infections. Infection 7 (Suppl 4), S398–S400 (1979). https://doi.org/10.1007/BF01639020
Issue Date:
DOI: https://doi.org/10.1007/BF01639020